Drug Type Small molecule drug |
Synonyms 2',4'-difluoro-4-hydroxy-3-biphenylcarboxylic acid, 2-(hydroxy)-5-(2,4-difluorophenyl)benzoic acid, 5-(2,4-difluorophenyl)salicylic acid + [6] |
Target |
Mechanism COX inhibitors(Cyclooxygenases inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (19 Apr 1982), |
RegulationOrphan Drug (EU) |
Molecular FormulaC13H8F2O3 |
InChIKeyHUPFGZXOMWLGNK-UHFFFAOYSA-N |
CAS Registry22494-42-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00130 | Diflunisal |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Osteoarthritis | US | 19 Apr 1982 | |
Pain | US | 19 Apr 1982 | |
Rheumatoid Arthritis | US | 19 Apr 1982 |
Phase 2/3 | 130 | (Diflunisal) | iteiqacrxo(xfcccpttan) = mcjjzzyzgw nbtamsnmha (hddzbmaulg, udizjzsmdk - gmwwydzofd) View more | - | 17 Mar 2017 | ||
placebo (Placebo) | iteiqacrxo(xfcccpttan) = sjsczvlwbf nbtamsnmha (hddzbmaulg, vijmlsiyoc - jnplsztexc) View more | ||||||
Phase 2/3 | 130 | ueqimkruhp(rrzmmeyzdw) = lvgmfkaqqh pvfoyxknte (eduqfxmquz, 3.3 - 14.1) View more | Positive | 25 Dec 2013 | |||
Placebo | ueqimkruhp(rrzmmeyzdw) = rozcpggrfo pvfoyxknte (eduqfxmquz, 18.4 - 31.6) View more | ||||||
Not Applicable | Amyloid Neuropathies, Familial ATTR Val30Met FAP | 18 | ykmrweshah(pfvjfdjlwk) = deterioration of renal function resulted in discontinuation of the study drug in two patients oomymeozrq (iinvgrlisg ) View more | Positive | 12 Feb 2013 | ||